These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7945555)

  • 1. Atherogenic levels of low density lipoprotein alter the permeability and composition of the endothelial barrier.
    Guretzki HJ; Gerbitz KD; Olgemöller B; Schleicher E
    Atherosclerosis; 1994 May; 107(1):15-24. PubMed ID: 7945555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High concentrations of low density lipoprotein decrease basement membrane-associated heparan sulfate proteoglycan in cultured endothelial cells.
    Olgemöller B; Schleicher ED; Schwaabe S; Guretzki HJ; Gerbitz KD
    FEBS Lett; 1990 May; 264(1):37-9. PubMed ID: 2140100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin induces endothelial extracellular matrix alterations and barrier dysfunction.
    Guretzki HJ; Schleicher E; Gerbitz KD; Olgemöller B
    Am J Physiol; 1994 Oct; 267(4 Pt 1):C946-54. PubMed ID: 7943290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.
    Pillarisetti S; Paka L; Obunike JC; Berglund L; Goldberg IJ
    J Clin Invest; 1997 Aug; 100(4):867-74. PubMed ID: 9259586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity.
    Pillarisetti S
    Trends Cardiovasc Med; 2000 Feb; 10(2):60-5. PubMed ID: 11150731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta.
    Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
    Biochim Biophys Acta; 1983 Jul; 758(1):70-83. PubMed ID: 6222769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin induces changes in the synthesis of porcine aortic endothelial cell heparan sulfate proteoglycans.
    Morrison P; Lowe-Krentz LJ
    Exp Cell Res; 1989 Oct; 184(2):304-15. PubMed ID: 2530099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface determinants of low density lipoprotein uptake by endothelial cells.
    Görög P; Pearson JD
    Atherosclerosis; 1984 Oct; 53(1):21-9. PubMed ID: 6497941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of endothelial barrier function by lipolytic remnants of triglyceride-rich lipoproteins.
    Hennig B; Chung BH; Watkins BA; Alvarado A
    Atherosclerosis; 1992 Aug; 95(2-3):235-47. PubMed ID: 1418097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized lipid-mediated alterations in proteoglycan metabolism in cultured pulmonary endothelial cells.
    Ramasamy S; Lipke DW; Boissonneault GA; Guo H; Hennig B
    Atherosclerosis; 1996 Feb; 120(1-2):199-208. PubMed ID: 8645361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
    Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
    Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P; Feitsma K; Schön P; Völker W
    Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of heparan sulfate proteoglycans enhances oxidized-LDL-mediated autophagy and apoptosis in human endothelial cells.
    Ding Z; Wang X; Khaidakov M; Liu S; Dai Y; Mehta JL
    Biochem Biophys Res Commun; 2012 Sep; 426(1):106-11. PubMed ID: 22910414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low-density lipoproteins on the synthesis and secretion of proteoglycans by human endothelial cells in culture.
    Vijayagopal P; Srinivasan SR; Dalferes ER; Radhakrishnamurthy B; Berenson GS
    Biochem J; 1988 Oct; 255(2):639-46. PubMed ID: 3202837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxysterol-enriched low-density lipoprotein on endothelial barrier function in culture. Low-density lipoproteins.
    Boissonneault GA; Hennig B; Wang Y; Ouyang CM; Krahulik K; Cunnup L; Oeltgen PR
    Ann Nutr Metab; 1991; 35(4):226-32. PubMed ID: 1897903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis.
    Nielsen LB
    Atherosclerosis; 1996 Jun; 123(1-2):1-15. PubMed ID: 8782833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor increases human cardiac microvascular endothelial cell permeability to low-density lipoproteins.
    Wong BW; Rahmani M; Luo Z; Yanagawa B; Wong D; Luo H; McManus BM
    J Heart Lung Transplant; 2009 Sep; 28(9):950-7. PubMed ID: 19716049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basement membrane heparan sulfate proteoglycan is the main proteoglycan synthesized by glomerular epithelial cells in culture.
    Stow JL; Soroka CJ; MacKay K; Striker L; Striker G; Farquhar MG
    Am J Pathol; 1989 Oct; 135(4):637-46. PubMed ID: 2529772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells.
    Jougasaki M; Kugiyama K; Saito Y; Nakao K; Imura H; Yasue H
    Circ Res; 1992 Sep; 71(3):614-9. PubMed ID: 1499109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous distribution of a basement membrane heparan sulfate proteoglycan in rat tissues.
    Couchman JR
    J Cell Biol; 1987 Oct; 105(4):1901-16. PubMed ID: 2959669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.